Re: Liu et al.,Effectiveness and safety of opioids on breathlessness and exercise endurance in patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis of randomised controlled trials

Abstract

Get full access to this article

View all access options for this article.

References

Liu

Xiao

, et al. Effectiveness and safety of opioids on breathlessness and exercise endurance in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis of randomised controlled trials. Palliat Med 2023; 37(9): 1365–1378.

Ekström

. Why treatment efficacy on breathlessness in laboratory but not daily life trials? The importance of standardized exertion. Curr Opin Support Palliat Care 2019; 13(3): 179–183.

Curtin

Altman

Elbourne

. Meta-analysis combining parallel and cross-over clinical trials. I: continuous outcomes. Stat Med 2002; 21(15): 2131–2144.

Janssen

DJA

van den Beuken-van Everdingen

MHJ

Verberkt

, et al. Fentanyl nasal spray in a patient with end-stage COPD and severe chronic breathlessness. Breathe 2019; 15: e122–e125.

Smallwood

Politis

. Predictable adverse events such as respiratory depression highlight the need for caution when prescribing morphine for refractory breathlessness. Eur Respir J 2017; 50(3): 1701357.

Ekström

Elmberg

Lindow

, et al. Breathlessness measurement should be standardised for the level of exertion. Eur Respir J 2018; 51(5): 1800486.